Journal of Oncology Practice · 2011 · 47 citations · 9 references
PharmacyOncologyPharmacologyChemotherapyClinical PharmacologyOncology Medication SafetyChemotherapy Toxicity ManagementDrug Safety MonitoringMedication SafetyMedication Side Effect ManagementToxicity ManagementToxicity Risk AssessmentChemotherapy Medication SafetyChemotherapy Toxicity Risk AssessmentChemotherapy-related Oral ToxicityFailure ModesMedication Process ImprovementMedication Use Process EvaluationMedication Use Process SafetyOral Chemotherapy Safety
PURPOSE: Oral chemotherapies represent an emerging risk area in ambulatory oncology practice. To examine the hazards associated with five oral chemotherapies, we performed a proactive risk assessment. METHODS: WE CONVENED INTERDISCIPLINARY TEAMS AND CONDUCTED FAILURE MODE AND EFFECTS ANALYSES (FMEAS) FOR FIVE ORAL CHEMOTHERAPY AGENTS: capecitabine, imatinib, temozolomide, 6-mercaptopurine, and an investigational agent. This involved the creation of process maps for each medication, identification of failure modes, selection of high-risk failure modes, and development of recommendations to mitigate these risks. We analyzed the number of steps and types of failure modes and compared this information across the study drugs. RESULTS: Key vulnerabilities include patient education about drug handling and adverse effects, prescription writing, patient self-administration and medication adherence, and failure to monitor and manage toxicities. Many of these failure modes were common across the five oral chemotherapies, suggesting the presence of common targets for improvement. Streamlining the FMEA itself may promote the dissemination of this method. CONCLUSION: Each stage of the medication process poses risks to the safe use of oral chemotherapies. FMEAs may identify opportunities to improve medication safety and reduce the risk of patient harm.
9
Nonadherence to Adjuvant Tamoxifen Therapy in Women With Primary Breast Cancer
Ann H. Partridge, Philip S. Wang, Eric P. Winer et al. · Journal of Clinical Oncology · 2003 · 680 citations
Medicine, Oncology, Pharmacotherapy +12
Joseph DeRosier, Erik Stalhandske, James P. Bagian et al. · The Joint Commission Journal on Quality Improvement · 2002 · 611 citations
Health Professions, Health Services Administration, Patient Safety +9
NCCN Task Force Report: Oral Chemotherapy
Saul N. Weingart, Elizabeth Brown, Peter B. Bach et al. · Journal of the National Comprehensive Cancer Network · 2008 · 436 citations · Full text
Medicine, Oncology, Oncology Nursing +13
Medication Errors Among Adults and Children With Cancer in the Outpatient Setting
Kathleen E. Walsh, Katherine Dodd, Kala Seetharaman et al. · Journal of Clinical Oncology · 2008 · 207 citations · Full text
Medicine, Oncology, Pediatrics +11
Oral chemotherapy safety practices at US cancer centres: questionnaire survey
Saul N. Weingart, Jonathan A. Flug, Daniela Brouillard et al. · BMJ · 2007 · 110 citations · Full text